SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-013129
Filing Date
2016-05-10
Accepted
2016-05-10 16:27:19
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0316_actiniumpharma.htm 10-Q 487649
2 CERTIFICATION f10q0316ex31i_actinium.htm EX-31.1 14425
3 CERTIFICATION f10q0316ex32i_actinium.htm EX-32.1 7586
  Complete submission text file 0001213900-16-013129.txt   3033095

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE atnm-20160331.xml EX-101.INS 444254
5 XBRL SCHEMA FILE atnm-20160331.xsd EX-101.SCH 43673
6 XBRL CALCULATION FILE atnm-20160331_cal.xml EX-101.CAL 25877
7 XBRL DEFINITION FILE atnm-20160331_def.xml EX-101.DEF 136844
8 XBRL LABEL FILE atnm-20160331_lab.xml EX-101.LAB 376071
9 XBRL PRESENTATION FILE atnm-20160331_pre.xml EX-101.PRE 238743
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 161636151
SIC: 2834 Pharmaceutical Preparations